Microbiota changes: the unseen players in cervical cancer progression
View abstract on PubMed
Summary
This summary is machine-generated.Changes in the vaginal microbiota may signal cervical cancer progression. Specific bacteria like Fusobacterium and Peptostreptococcus show potential as biomarkers, warranting further research into the microbial role in HPV development.
Area Of Science
- Gynecology
- Microbiology
- Oncology
Background
- Cervical cancer is a global health concern, with high-risk human papillomaviruses (HPVs) implicated in most cases.
- Emerging research suggests the vaginal microbiota may serve as a marker for cervical cancer progression.
- Understanding these microbial shifts is crucial for advancing diagnostic and therapeutic strategies.
Purpose Of The Study
- To comprehensively review microbiota alterations associated with cervical cancer advancement.
- To analyze existing studies on microbial profiles in healthy versus cancerous cervical stages.
- To identify potential microbial biomarkers linked to cervical cancer and HPV status.
Main Methods
- Systematic review and meta-analysis of published studies on cervical microbiota.
- Comparison of microbial communities in healthy, precancerous (CIN, SIL), and cancerous cervical tissues.
- Analysis of associations between specific bacterial genera and HPV infection status.
Main Results
- Potential biomarkers for cervical cancer progression include Fusobacterium spp., Peptostreptococcus spp., Campylobacter spp., and Haemophilus spp.
- Alloscardovia spp., Eubacterium spp., and Mycoplasma spp. may indicate HPV positivity.
- Methylobacterium spp. might be indicative of HPV negativity.
Conclusions
- Distinct bacterial genera differentiate cancerous from healthy cervical samples, suggesting a role in pathogenesis.
- The identified microbial signatures offer potential as biomarkers for cervical cancer and HPV status.
- Further research is needed to validate findings and explore the microbiota's role in HPV development and cervical disease.
Related Concept Videos
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...

